SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) receives sales order of around Rs 1.20 crore

18 Aug 2023 Evaluate

Syschem (India) has received sales order worth around Rs 1.20 crore only from Sunlovis Pharmaceuticals LLP towards Supply of Cephalexin Monohydrate (Compacted) BP; 1325 KGS and 1450 KG, 1AMOX02 Amoxicillin Trihydrate BP HSN/SAC. The said order is expected to be completed within 30 days.

Syschem (India) is a listed company engaged in the manufacture of Bulk Drugs/ Intermediates / Specialty Chemicals and contract manufacturing.


Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×